These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Macdougall BR; Bailey RJ; Williams R Lancet; 1977 Mar; 1(8012):617-9. PubMed ID: 66425 [TBL] [Abstract][Full Text] [Related]
47. Should we be changing our operative strategies for the acute complications of peptic ulcer disease? Jamieson GG Aust N Z J Surg; 1988 Jul; 58(7):525-7. PubMed ID: 2908172 [TBL] [Abstract][Full Text] [Related]
48. Pharmacologic prophylaxis and treatment of stress ulcers in critically ill patients. Flannery J; Tucker DA Crit Care Nurs Clin North Am; 2002 Mar; 14(1):39-51. PubMed ID: 11939644 [TBL] [Abstract][Full Text] [Related]
49. [Formation of a gastric bezoar following upper digestive hemorrhage caused by a medically-treated ulcer]. Gentile F; Tempesti M; Mancini P J Radiol; 1984; 65(6-7):475-6. PubMed ID: 6092631 [TBL] [Abstract][Full Text] [Related]
50. [Indications and results of surgical treatment of ulcers. Considerations after the introduction of H2-receptor antagonists]. Barner S; Waldmann D; Farthmann EH Fortschr Med; 1984 Jul; 102(25-26):692-6. PubMed ID: 6147305 [TBL] [Abstract][Full Text] [Related]
55. H2 antagonists in the treatment of upper gastrointestinal bleeding. Langman MJ Scand J Gastroenterol Suppl; 1988; 146():185-90. PubMed ID: 2906463 [TBL] [Abstract][Full Text] [Related]
56. The role of acid suppression in the management and prevention of gastrointestinal hemorrhage associated with gastroduodenal ulcers. Sung JJ Gastroenterol Clin North Am; 2003 Sep; 32(3 Suppl):S11-23. PubMed ID: 14556432 [TBL] [Abstract][Full Text] [Related]
57. Optimal therapy for stress gastritis. Maier RV; Mitchell D; Gentilello L Ann Surg; 1994 Sep; 220(3):353-60; discussion 360-3. PubMed ID: 8092901 [TBL] [Abstract][Full Text] [Related]
58. Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of endoscopically proven stress ulceration. Devlin JW; Ben-Menachem T; Ulep SK; Peters MJ; Fogel RP; Zarowitz BJ Ann Pharmacother; 1998 Sep; 32(9):869-74. PubMed ID: 9762371 [TBL] [Abstract][Full Text] [Related]
59. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol. Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM; Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780 [TBL] [Abstract][Full Text] [Related]
60. [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer]. Alekseenko SA; Timoshin SS Ter Arkh; 1999; 71(2):23-6. PubMed ID: 10222548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]